- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: LCCC 1210
Total 579 results
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingGastric Cancer | GastroEsophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownCarcinoma, Non-Small-Cell LungChina
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedMetastatic Colorectal CancerChina
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.UnknownNeoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-small-cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Lung Neoplasms | Carcinoma, Bronchogenic | Lung Disease | Respiratory Tract Disease | Respiratory Tract Neoplasms Nec | Neoplasm, BronchialChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLung Diseases | Neoplasms by Site | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Respiratory Tract Disease | Neoplasm, BronchialChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingResectable Esophageal Squamous Cell Carcinoma
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedLung NeoplasmsChina
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Guangdong Association of Clinical TrialsNot yet recruitingNon-small Cell Lung Cancer
-
Beijing Sanbo Brain HospitalRecruitingPrimary Central Nervous System LymphomaChina
-
Guangdong Association of Clinical TrialsUnknown
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGastric Cancer | GastroEsophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Yanqiao ZhangNot yet recruiting
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.UnknownNon-Small-Cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...Unknown
-
Tianjin Medical University Cancer Institute and...Not yet recruitingEsophageal Squamous Cell Carcinoma | Progression to PD-1 AntibodyChina
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Qian ChuJiangsu HengRui Medicine Co., Ltd.RecruitingSarcomatoid Carcinoma of LungChina
-
United States Naval Medical Center, San DiegoCandela Corp.Unknown
-
Shanghai Chest HospitalNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHepatocellular Carcinoma Non-ResectableChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHodgkin Lymphoma, AdultChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.UnknownEsophageal CancerChina
-
University of ZurichUniversity of LausanneCompleted
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.UnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.CompletedEsophageal Neoplasms | Esophageal Diseases | Esophageal Squamous Cell CarcinomaChina
-
Henan Cancer HospitalUnknownAdvanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210China
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNasopharyngeal CarcinomaChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedBreast Cancer | Solid Tumor | Gastrointestinal CancerChina
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Peking Union Medical College HospitalNot yet recruitingAnlotinib | Advanced Esophageal Squamous Cell Cancer | SHR-1210
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingNeoplasm Malignant | Tumor, Solid | Cancer, MetastaticChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.UnknownEsophageal Squamous Cell CarcinomaChina
-
Chinese PLA General HospitalRecruitingHodgkin LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Hepatocellular CarcinomaChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingExtensive Stage Small Cell Lung Cancer
-
UNC Lineberger Comprehensive Cancer CenterCelgeneCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.CompletedCholangiocarcinoma | Biliary Tract CancerChina